Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001140361-22-001654

10% owner bought 2,300,000 shares at $19.00 ($43,700,000)

  • 10% owner acquired 4,870,536 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
VIKING GLOBAL INVESTORS LP 10% owner 2022-01-11 Conversion +4,870,536 4,870,536 I: show line 1 in the form
VIKING GLOBAL INVESTORS LP 10% owner 2022-01-11 Purchase +2,300,000 $19.00 $43,700,000 2,300,000 I: show line 2 in the form
Open-market purchases · 2,300,000 sh · avg $19.00 · $43,700,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
VIKING GLOBAL INVESTORS LP 10% owner 2022-11-11 Conversion · Series C-1 Preferred Stock −4,870,536 0 I: show line 3 in the form
Loading xslF345X03/form4.xml…